
Blood Biomarkers Predict Cognitive Decline Years Before Symptoms Appear
A University of Miami study finds that blood levels of p-tau181 and GFAP can predict memory and cognitive decline up to six years before symptoms manifest. While these biomarkers offer early warning signs, experts caution that positive results do not guarantee dementia and should not be used for asymptomatic screening.
